Just thinking simply if Neuren gets 70m USD from first sales milestone and sale of the priority voucher then announces a 30m USD up front payment for ROW deal that's $150m in Aussie dollars without any royalties. Assuming 20m in expenses for all the phase 2 trials on the go and 30% tax on the profit then you're looking at earnings over 90m so about 70c per share. At a conservative PE ratio of 30 that's over $20 per share. I don't know how the timing of these things play out and how quickly sales will come on but all I've put down here seems very doable to me as a low end before the next Annual report is due.
Share Price, page-4441
-
- There are more pages in this discussion • 6,370 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.000(0.00%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.97 | $19.69 | $4.156M | 209.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 246 | $19.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 512 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |